Previous Question
183. A new medicinal drug is being tested for a very rare disease, where it's unethical to withhold treatment from a placebo group. What technical alternative study design might be considered?
Next Question
185. A clinical epidemiologist is evaluating a new screening test for colon cancer. What epidemiological concept helps them understand how often the test correctly identifies true positives among all those who test positive?
